Armata Pharmaceuticals (ARMP) Institutional Ownership $2.47 -0.03 (-1.16%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$57KNumber ofInstitutional Sellers(last 12 months)2 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/15/2025 GSB Wealth Management LLC30,000$57K0.0%N/A0.083% 2/17/2025Bridgeway Capital Management LLC69,682$129K0.0%-7.6%0.193% 2/13/2025Renaissance Technologies LLC40,291$75K0.0%-13.3%0.111% 4/18/2024 SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021 Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021Millennium Management LLC15,401$74K0.0%N/A0.062% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K), Bridgeway Capital Management LLC ($129K), and Renaissance Technologies LLC ($75K), GSB Wealth Management LLC ($57K).Learn more on Armata Pharmaceuticals' institutional investors. What percentage of Armata Pharmaceuticals' stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals' stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals' stock? The following institutional investors have purchased Armata Pharmaceuticals' stock in the last 24 months: GSB Wealth Management LLC ($30K), and SeaCrest Wealth Management LLC ($14.65K). How much institutional buying is happening at Armata Pharmaceuticals? Institutional investors have bought a total of 30,000 shares in the last 24 months. This purchase volume represents approximately $57K in transactions. Which of Armata Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Armata Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($6.21K), and Bridgeway Capital Management LLC ($5.70K). How much institutional selling is happening at Armata Pharmaceuticals? Institutional investors have sold a total of 11,905 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies Fulcrum Therapeutics Institutional Ownership Capricor Therapeutics Institutional Ownership Esperion Therapeutics Institutional Ownership Olema Pharmaceuticals Institutional Ownership Aura Biosciences Institutional Ownership Tonix Pharmaceuticals Institutional Ownership Humacyte Institutional Ownership Abeona Therapeutics Institutional Ownership Nanobiotix Institutional Ownership I-Mab Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access